eLife

Generative artificial intelligence tools such as ChatGPT or AI using large language models to generate article content are at an essential level just tools as, for example, imaging or statistical software. Whilst such AI tools might be used to aid researchers and authors in doing their work, they cannot be listed as or serve as co-authors of a paper, and their use must be clearly described in the …

Author contributions use CRediT taxonomy. 模型摘要

eLife seeks to ensure that authorship is equitable, and that researchers are fairly recognised for their contributions. We recommend that all researchers who made substantial or important contributions to the design of a work, or the acquisition, analysis or interpretation of the data used in the paper, be included as authors. Authors should also ideally be involved in writing and editing the manu…

Competing interests must be declared for each author. 模型摘要

ICMJE states that the “potential for conflict of interest and bias [competing interests] exists when professional judgment concerning a primary interest (such as patients' welfare or the validity of research) may be influenced by a secondary interest (such as financial gain)”. Authors, reviewers, and editors are all required to declare any competing interests that might be perceived to interfere w…

Purpose and General Principles To maintain high standards of research reproducibility, and to promote the reuse of new findings, eLife requires all data associated with an article to be made freely and widely available. These must be in the most useful formats and according to the relevant reporting standards, unless there are compelling legal or ethical reasons to restrict access. The provision o…

If we receive an allegation of potential research or publication misconduct, we will alert those affected and ask for their response. We reserve the right to suspend the review process where necessary; to publish an expression of concern for published papers where appropriate; and/or to ask the relevant employers, or institution, or an appropriate regulatory body to investigate. If someone has con…

Creative Commons Attribution license, except where otherwise noted 模型摘要

Subject to a Creative Commons Attribution license, except where otherwise noted.

As defined by COPE, plagiarism is “when somebody presents the work of others (data, words or theories) as if they were his/her own and without proper acknowledgment”, and self-plagiarism (also known as text recycling) is the “copying from author’s own work without attribution”. Manuscripts selected by eLife for peer review may be screened for plagiarism using Crossref Similarity Check (powered by …

Once a preprint has been peer-reviewed by eLife, we publish a Reviewed Preprint: this includes the full text of the preprint, the eLife assessment, the public peer reviews, and (if the authors wish) a response from the authors. Reviewed Preprints will receive a DOI and eLife citation. The Reviewed Preprint will typically be posted on the eLife website within two weeks of the conclusion of the peer…

eLife mandates that clinical investigators reporting phase II and phase III clinical studies must follow the CONSORT Statement for reporting of results. Submissions not in compliance with the guidelines will be returned to the authors before review. REMARK and BRISQ guidelines should be used to report studies with tumor biomarkers and human biospecimens, respectively. All clinical trials, with the…